Scientific publications

Scientific articles authored by Novo Nordisk

The information you can search here is retrieved via the database Current Contents®, covering 95% of publications within the life science area. Only articles authored by at least one researcher from Novo Nordisk are included in the search results. The database provides easy access to tables of contents, abstracts, bibliographic information, and abstracts from the most recently published issues of leading scholarly journals.

4638 results found.
Showing results 2821-2840
Journal Author Year
Diabetic Medicine

Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy

Theilade S ; Lajer M ; Jorsal A ; Tarnow L ; Parving HH ; Rossing P 2012
Diabetic Medicine

Can sharing experiences in groups reduce the burden of living with diabetes, regardless of glycaemic control?

Due-Christensen M ; Zoffmann V ; Hommel E ; Lau M 2012
Diabetic Medicine

Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes

Secher AL ; Madsen AB ; Ringholm L ; Barfred C ; Stage E ; Andersen HU ; Damm P ; Mathiesen ER 2012
Diabetic Medicine

Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies

Soulimane S ; Simon D ; Shaw JE ; Zimmet PZ ; Vol S ; Vistisen D ; Magliano DJ ; Borch-Johnsen K ; Balkau B 2011
Diabetic Medicine

Cognitive function in adult offspring of women with Type 1 diabetes

Clausen TD ; Mortensen EL ; Schmidt L ; Mathiesen ER ; Hansen T ; Jensen DM ; Holm S ; Poulsen L ; From M ; Damm P 2011
Diabetic Medicine

Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metformin

Davies M ; Pratley R ; Hammer M ; Thomsen AB ; Cuddihy R 2011
Diabetic Medicine

Pharmacokinetics and pharmacodynamics of different modes of insulin pump delivery. A randomized, controlled study comparing subcutaneous and intravenous administration of insulin aspart

Ihlo CA ; Lauritzen T ; Sturis J ; Skyggebjerg O ; Christiansen JS ; Laursen T 2011
Diabetic Medicine

Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study

Schmidt WE ; Christiansen JS ; Hammer M ; Zychma MJ ; Buse JB 2011
Diabetic Medicine

Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA(1c)The Danish Inter99 study

Borg R ; Vistisen D ; Witte DR ; Borch-Johnsen K 2010
Diabetic Medicine

Similarity of pharmacodynamic effects of a single injection of insulin glargine, insulin detemir and NPH insulin on glucose metabolism assessed by 24-h euglycaemic clamp studies in healthy humans

Sorensen LP ; Brock B ; Mengel A ; Rungby J ; Moller N ; Nielsen S ; Volund A ; Schmitz O 2010
Diabetic Medicine

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

Nielsen SE ; Schjoedt KJ ; Astrup AS ; Tarnow L ; Lajer M ; Hansen PR ; Parving HH ; Rossing P 2010
Diabetic Medicine

Performance of existing risk scores in screening for undiagnosed diabetes: an external validation study

Witte DR ; Shipley MJ ; Marmot MG ; Brunner EJ 2010
Diabetic Medicine

Advantages of insulin pump therapy

Akram K ; Pedersen-Bjergaard U ; Carstensen B ; Borch-Johnsen K ; Thorsteinsson B 2009
Diabetic Medicine

Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins

Arutchelvam V ; Heise T ; Dellweg S ; Elbroend B ; Minns I ; Home PD 2009
Diabetic Medicine

Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naive patients with Type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research Consortium

Makine C ; Karsidag C ; Kadioglu P ; Ilkova H ; Karsidag K ; Skovlund SE ; Snoek FJ ; Pouwer F 2009
Diabetic Medicine

Socioeconomic factors related to attendance at a Type 2 diabetes screening programme

Dalsgaard EM ; Lauritzen T ; Christiansen T ; Mai KS ; Borch-Johnsen K ; Sandbaek A 2009
Diabetic Medicine

Predictors of future fasting and 2-h post-OGTT plasma glucose levels in middle-aged men and women-the Inter99 study

Faerch K ; Vaag A ; Witte DR ; Jorgensen T ; Pedersen O ; Borch-Johnsen K 2009
Diabetic Medicine

Safety and efficacy of inhaled insulin (AERx((R)) iDMS(1)) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial

Moses RG ; Bartley P ; Lunt H ; O'Brien RC ; Donnelly T ; Gall MA ; Vesterager A ; Wollmer P ; Roberts A 2009
Diabetic Medicine

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

Marre M ; Shaw J ; Brandle M ; Bebakar WMW ; Kamaruddin NA ; Strand J ; Zdravkovic M ; Le Thi TD ; Colagiuri S 2009
Diabetic Medicine

Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes

Hojberg PV ; Vilsboll T ; Zander M ; Knop FK ; Krarup T ; Volund A ; Holst JJ ; Madsbad S 2008